info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Smart Biosensors Market Share

ID: MRFR//6331-HCR | 85 Pages | Author: Kinjoll Dey| November 2024

With a developing emphasis on health awareness and preventive medical care, buyers are effectively looking for innovations that empower ceaseless observing of their health. Smart biosensors work with ongoing information variety, enabling people to proactively deal with their prosperity and anticipate potential medical problems.
Continuous mechanical progressions in the field of biosensors are energizing market development. Smart Biosensors are turning out to be more complex, with improved abilities for exact and fast identification of biomarkers. This advancement is opening additional opportunities in clinical diagnostics, natural checking, and sanitation.
The frequency of persistent illnesses is on the rise internationally, prompting an elevated spotlight on compelling infection management. Smart biosensor spreads an essential job in ceaseless observing of fundamental signs and biomarkers, offering important information for overseeing persistent circumstances like diabetes, cardiovascular illnesses, and respiratory problems.
The reconciliation of smart biosensors with the web of Things (IoT) is a key market factor. This availability permits consistent information move to smartphones or different gadgets, empowering remote checking and giving medical services experts continuous data. This interconnection improves patient consideration and adds to the development of the biosensors market.
Smart biosensors are tracking down applications past medical services, adding to their market extension. Businesses like natural observing, food and refreshment, and guard are progressively using biosensors for recognizing toxins, guaranteeing hygiene, and improving safety efforts.
As innovation develops, the expense of assembling smart biosensors is diminishing. this cost decrease is making biosensors more open to a more extensive market, including buyers and limited scope medical services offices, further driving market development.
The pattern towards decentralized medical services and purpose in care testing is supporting the reception of smart biosensors. These sensors give fast and solid outcomes, diminishing the reliance on concentrated labs and empowering quick dynamic in different medical care settings.

Covered Aspects:

Report Attribute/Metric Details
Base Year For Estimation   2021
Forecast Period 2023-2032
Growth Rate 6.9%

Global Smart Biosensors Market Overview


The Smart Biosensors market is anticipated to reach USD 27.21 Billion by 2032 at 6.9% CAGR during the forecast period 2023-2032.


Biosensors are analytical devices used for detection of chemical and biological substances in the human body. Smart biosensors are easy to use, simple, accurate and effective than traditional methods of analysis. Biosensors are becoming popular in developed countries. The increasing prevalence of diabetes in emerging economies, demand for advanced monitoring systems, and increasing awareness about advance biosensors are expected to drive the growth of the market. According to the report published by World Health Organization(WHO) in 2016, diabetes is a major healthcare concern in Brazil, and it affected more than 8.1% of the population, the prevalence of diabetes was more in females, and it affected more than 8.8% females in the country. Moreover, rising R&D spending and collaborative strategies adopted by the top players such as new product launches and collaborations for product development are contributing to the growth of the market.


The rising cost of biosensors and unfavorable reimbursement policies may hamper the growth of the market during the assessment period.


Smart Biosensors Market


Smart Biosensors Market Segment Insights


The global smart biosensors market has been segmented on the basis of product type, technology, application, and end user.


On the basis of product type, the market has been classified as wearable biosensors, non-wearable biosensors.


The technology segment has been divided into electrochemical biosensors, piezoelectric biosensors, optical biosensors, thermal biosensors, nanomechanical biosensors, and others. thermal biosensors segment is likely to be the fastest growing segment during the forecast period.


The market, by application, has been segmented into blood glucose testing, cholesterol testing, blood gas analysis, pregnancy testing, drug discovery, infectious disease testing, and others.


The end user segment has been divided into point-of-care, home diagnostics, research labs, security & biodefense, environmental monitoring, food & beverage industry, and others


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The smart biosensors market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European smart biosensors market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The smart biosensors market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The smart biosensors market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Smart Biosensors Market Share, by Region (%)


Global Smart Biosensors Market Share, by Region, 2017


Source: MRFR Analysis


The Americas are expected to hold the maximum share of global smart biosensors market owing to the rising prevalence of chronic disorders, favorable policies implemented by government and regulatory authorities, and adoption of highly advanced technology. According to the article published in 2016 by National Council on Aging, the prevalence of Chronic disorders in American regions is continuously increasing and about 80 percent of older adults have at least one chronic disease, and more than 68 percent were suffering from more than one chronic disorders.


The European market is likely to be the second-largest smart biosensors market. The market growth in this region can be attributed to the presence of well-established healthcare system in the region, government initiatives for controlling chronic disorders, and increase in the population suffering from cardiovascular disorders. According to the European Heart Network, cardiovascular disorders are responsible for 3.9 million deaths in the European Union which are 45% of the total deaths.


Asia-Pacific is expected to be the fastest-growing smart biosensors market during the forecast period owing to the increasing prevalence of diabetes, increasing disposable income, and government initiatives for the development of the healthcare sector. According to the International Diabetes Federation, in 2017, more than 84 million people in South-East Asia were affected by diabetes, and this number is expected to reach 156 million by 2045.


The market in the Middle East & Africa is expected to hold the smallest share of the global smart biosensors market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global smart biosensors market are Abbott Point of Care Inc., Medtronic Inc., F. Hoffman La-Roche Ltd., Siemens Healthcare AG, Lifescan, Inc., LifeSensors Inc., Nova Biomedical Corp., Acon Laboratories Inc., Universal Biosensors, Pharmaco-Kinesis Corporation, Biacore, and Others


Smart Biosensors Market Segmentation


Global Smart Biosensors Market, by Product Type



  •  Wearable Biosensors

  • Non-wearable Biosensors


Global Smart Biosensors Market, by Technology



  • Electrochemical Biosensors

  • Piezoelectric Biosensors

  • Optical Biosensors

  • Thermal Biosensors

  • Nanomechanical Biosensors

  • Others


Global Smart Biosensors Market, by Application



  • Blood Glucose Testing

  • Cholesterol Testing

  • Blood Gas Analysis

  • Pregnancy Testing

  • Drug Discovery

  • Infectious Disease Testing

  • Others


Global Smart Biosensors Market, by End User



  • Point-Of-Care

  • Home Diagnostics

  • Research Labs

  • Security & Biodefense

  • Environmental Monitoring

  • Food & Beverage Industry

  • Others


Global Smart Biosensors Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




Company Profiles 

  • Abbott Point of Care Inc.

  • Medtronic Inc.

  • Hoffman La-Roche Ltd.

  • Siemens Healthcare AG

  • Lifescan, Inc.

  • LifeSensors Inc.

  • Nova Biomedical Corp.

  • Acon Laboratories Inc.

  • Universal Biosensors

  • Pharmaco-Kinesis Corporation

  • Biacore


Intended Audience



  • Biosensor manufacturers

  • Biosensor distributors and suppliers

  • Healthcare providers

  • Medical device manufacturers

  • Research institutes and academic centers

  • Contract research organizations (CROs)

  • Government associations

  • Market research and consulting

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.